Psychopharmacology and Psychiatry Updates

247 Episodo

1. SSRIs and Suicidality

   Publicado: 18/3/2022
2. Cannabis and Cognition

   Publicado: 13/3/2022
3. Clozapine-Induced Myocarditis

   Publicado: 8/3/2022
4. Does Cannabis Use Cause Psychiatric Disorders?

   Publicado: 3/3/2022
5. Treatment Strategies for Treatment-Resistant OCD

   Publicado: 26/2/2022
6. Lithium Augmentation for Psychotic Depression

   Publicado: 21/2/2022
7. Prevention and Treatment Strategies for Agitation and Dementia

   Publicado: 16/2/2022
8. Choosing an Antipsychotic for Psychotic Depression

   Publicado: 11/2/2022
9. Neurological and Psychiatric Sequelae Due to COVID-19

   Publicado: 6/2/2022
10. SNRIs + Antipsychotics for Psychotic Depression

    Publicado: 1/2/2022
11. Approaches for Addressing Tobacco Use Disorder

    Publicado: 27/1/2022
12. ECT the First-Choice Treatment for Psychotic Depression

    Publicado: 22/1/2022
13. Metabolic Characteristics of Newer Second-Generation Antipsychotics

    Publicado: 17/1/2022
14. Prescribing Antipsychotics During Breastfeeding

    Publicado: 12/1/2022
15. Fluvoxamine for Treating COVID-19

    Publicado: 7/1/2022
16. Prescribing Antidepressants During Breastfeeding

    Publicado: 2/1/2022
17. Treatment Strategies for Acute and Chronic Insomnia

    Publicado: 28/12/2021
18. Drug Use in Breastfeeding and Adverse Effects

    Publicado: 23/12/2021
19. Marine Omega-3 Fatty Acid Supplementation for BPD

    Publicado: 18/12/2021
20. Breastfeeding and Estimating Infant Drug Exposure

    Publicado: 13/12/2021